Abiopharma

Mirum Pharma - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc. - ELEV

KNOW LABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Know Labs, Inc. - KNW

New SEC Form for ResMed Inc.

ResMed Inc. Daily Stock Update

Shareholder Alert: Robbins LLP Informs Investors of the PepGen Inc. Class Action

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

Celularity Announces Chief Financial Officer Transition

Is Your Device Or Browser Running Slow? Do This To Get It Back Up To Speed